$COCO

Sadowsky Kenneth sold $323K of COCO

Sadowsky Kenneth sold 3,900 shares of Vita Coco Company, Inc. (COCO) at $82.92 ($0.32M total) on 2026-06-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Sadowsky Kenneth
Published Jun 18, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 11:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$COCO
Neutral
high confidence
Mentioned
$COCO
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$COCONeutralLow
01

Why it matters

The only new fact is the director’s sale size, price, and that it was executed under a pre-arranged 10b5-1 plan; no company performance or guidance change is mentioned.

02

Market read

Traders may note insider selling, but the 10b5-1 context suggests limited incremental information for valuation.

03

What to watch

The article does not state whether the sale was part of diversification, tax planning, or other non-informational motives, so the trading signal should be treated as weak.

Relevance 3/10Novelty 3/10Timing: filed 2026-06-18, transaction dated 2026-06-17

Background

This is an SEC Form 4 insider transaction disclosure for Vita Coco Company, Inc. (COCO).

Company-level read

Ticker impact

$COCONeutralHigh confidence
Context

Form 4 shows director Kenneth Sadowsky sold 3,900 COCO shares for about $323,372 under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any effect is likely limited to short-lived sentiment around insider selling.

Evidence & confidence

The disclosure specifies an open-market sale and confirms a pre-arranged 10b5-1 plan, which typically reduces the signal of new negative information.

Market effects

No sector read-through is provided beyond routine insider activity.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, but the 10b5-1 designation materially weakens that inference.

Key entities

  • Vita Coco Company, Inc.

    COCO, the company whose director insider sale is disclosed on Form 4.

  • Kenneth Sadowsky

    Director who sold 3,900 shares at $82.9160/share on 2026-06-17 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$COCOMed

Piper Sandler raises Vita Coco stock price target on earnings beat

Piper Sandler raised its price target for The Vita Coco Co. (NASDAQ:COCO) to $88 from $83, citing strong Q3 2026 results. The company reported 26.1% revenue growth and raised its sales guidance. Piper Sandler also increased its 2026 and 2027 EBITDA estimates. Vita Coco plans pricing increases to offset costs. The stock is trading at a low P/E ratio relative to earnings growth, with a PEG ratio of 0.45. Evercore ISI reiterated its Outperform rating with a $80 price target.

$COCOMedAI 8/10

Evercore ISI reiterates Vita Coco stock rating on demand strength

Evercore ISI reiterated an Outperform rating and $80 price target for The Vita Coco Co. Inc (COCO) after its Q3 results. The company beat expectations with $244M in net sales and $0.58 EPS, but shares fell 5% due to margin concerns. COCO's market cap is $3.63B, with shares down from a 52-week high of $85.83. Management expects low 20s% growth in 2026, up from prior forecasts. Supply chain issues have caused inventory shortages, but the company expects improvements in Q4 2026.

$COCOHighAI 8/10

The Vita Coco Co Inc (COCO) (Q3 2026) Earnings Call Highlights: Net Sales Surge 34%

The Vita Coco Co Inc (COCO) reported Q3 2026 net sales up 34% YoY to $244M, driven by strong coconut water and private label growth. International sales surged 48%. Full-year guidance was raised, but supply chain issues and cost pressures weighed on margins. Management expects capacity constraints to persist into early 2027 and deferred pricing to impact margins until then.

$COCOMed

Vita Coco (COCO) Q3 2026 Earnings Call Transcript

Vita Coco (COCO) reported Q3 2026 net sales up 34%, with coconut water and private label growth of 15% and 152% respectively. U.S. retail dollar sales grew 28%, while European markets saw 66% growth. The company plans to launch new products and expand supply chain capacity. Inflationary pressures impacted gross margins, with pricing adjustments expected in 2027.